QIAGEN OmicSoft and Biomedical Knowledge Base

Assessing drug safety with QIAGEN Biomedical KB-AI

320 views
July 24, 2024
Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs), we will also demonstrate how Neo4j and Python can be combined to query, visualize and analyze this data effectively.

We’ll cover the following:

• Drug safety profiling in Biomedical KB-AI
• Pharmacovigilance case study of ICIs: Pembrolizumab
• Comparative analysis of ICIs for comprehensive safety monitoring.

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

2,128 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN OmicSoft trainings- 3 part series - Oct 20 (part 1)

1,003 views October 26, 2021

In three separate 60-minute trainings, attendees will learn how to use basic...

QIAGEN IPA

Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity...

1,001 views June 18, 2021

In this 90-minute training, we will discuss how to discover and validate...